Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poonam Beniwal-Patel

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Crohn'S & Colitis 360|July 31, 2023
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective CohortEdward L Barnes, Poonam Beniwal-Patel, Parakkal Deepak, et al.
Journal of Crohn'S & Colitis|May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel DiseaseRyan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Crohn'S & Colitis 360|September 9, 2022
Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter RegistryEdward L Barnes, Parakkal Deepak, Poonam Beniwal-Patel, et al.
Inflammatory Bowel Diseases|February 28, 2019
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US CohortMartin Gregory, Kimberly N Weaver, Patrick Hoversten, et al.
The American Journal of Gastroenterology|June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L Barnes, Laura Raffals, Taha Qazi, et al.
Inflammatory Bowel Diseases|March 26, 2024
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort ConsortiumAndres J Yarur, Ryan Ungaro, Katherine Huang, et al.
Crohn'S & Colitis 360|December 22, 2023
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel DiseasePoonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Crohn'S & Colitis 360|July 31, 2023
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective CohortEdward L Barnes, Poonam Beniwal-Patel, Parakkal Deepak, et al.
Journal of Crohn'S & Colitis|May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel DiseaseRyan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Crohn'S & Colitis 360|September 9, 2022
Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter RegistryEdward L Barnes, Parakkal Deepak, Poonam Beniwal-Patel, et al.
Inflammatory Bowel Diseases|February 28, 2019
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US CohortMartin Gregory, Kimberly N Weaver, Patrick Hoversten, et al.
The American Journal of Gastroenterology|June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L Barnes, Laura Raffals, Taha Qazi, et al.
Inflammatory Bowel Diseases|March 26, 2024
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort ConsortiumAndres J Yarur, Ryan Ungaro, Katherine Huang, et al.
Crohn'S & Colitis 360|December 22, 2023
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel DiseasePoonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Pageof 3